日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials

一种基于具有复制能力的疱疹性口炎病毒的拉沙病毒候选疫苗的临床前开发已进入人体临床试验阶段。

Cooper, Christopher L; Morrow, Gavin; Yuan, Maoli; Postler, Thomas S; Neal, Maxwell L; Cross, Robert W; Woolsey, Courtney; Agans, Krystle N; Borisevich, Viktoriya; McNamara, Ryan P; Atyeo, Caroline; Roy, Vicky; Germosen, Daritza; Hou, Fuxiang; Li, Shui L; Reiserova, Lucia; Choi, Yesle; Wilson, Aaron; Wagner, Denise; Wallace-Selman, Olivia; Carpov, Alexei; Geng, Fuqiang; Frederick, Deborah J; DeStefano, Joanne; Ercolini, Anne M; Enriquez, Adrian S; Hastie, Kathryn M; Ramos da Silva, Suzane; Sayeed, Eddy; Coleman, John W; Kilianski, Andrew; Alter, Galit; Saphire, Erica Ollmann; Aitchison, John D; Geisbert, Thomas W; Gupta, Swati B; Feinberg, Mark B; Parks, Christopher L

Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera

基于水泡性口炎病毒-SARS-CoV-2 嵌合体的 COVID-19 候选疫苗的临床前免疫原性和有效性

Amy S Espeseth, Maoli Yuan, Michael Citron, Lucia Reiserova, Gavin Morrow, Aaron Wilson, Melanie Horton, Mark Rukhman, Keith Kinek, Fuxiang Hou, Shui L Li, Fengsheng Li, Yesle Choi, Gwen Heidecker, Bin Luo, Guoxin Wu, Lan Zhang, Erica Strable, Joanne DeStefano, Susan Secore, Tarit K Mukhopadhyay, Do

Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials

非人类灵长类动物可通过接种基于水泡性口炎病毒载体的疫苗来预防马尔堡病毒病,该疫苗是在允许进行人体临床试验的条件下制备的

Christopher L Cooper, Gavin Morrow, Maoli Yuan, John W Coleman, Fuxiang Hou, Lucia Reiserova, Shui L Li, Denise Wagner, Alexei Carpov, Olivia Wallace-Selman, Kristie Valentin, Yesle Choi, Aaron Wilson, Andrew Kilianski, Eddy Sayeed, Krystle N Agans, Viktoriya Borisevich, Robert W Cross, Thomas W Gei

Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeys

鞭毛蛋白-包膜融合登革热疫苗在小鼠和猴子中的免疫原性和有效性

Liu, Ge; Song, Langzhou; Beasley, David W C; Putnak, Robert; Parent, Jason; Misczak, John; Li, Hong; Reiserova, Lucia; Liu, Xiangyu; Tian, Haijun; Liu, Wenzhe; Labonte, Darlene; Duan, Lihua; Kim, Youngsun; Travalent, Linda; Wigington, Devin; Weaver, Bruce; Tussey, Lynda

Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin

重组鞭毛蛋白:H5N1 HA球状头部疫苗的卓越疗效取决于球状头部在鞭毛蛋白中的位置。

Langzhou Song ,Yi Zhang, Nadezhda E Yun, Allison L Poussard, Jeanon N Smith, Jennifer K Smith, Viktoriya Borisevich, Jenna J Linde, Michele A Zacks, Hong Li, Uma Kavita, Lucia Reiserova, Xiangyu Liu, Kunmi Dumuren, Bhuvaneswari Balasubramanian, Bruce Weaver, Jason Parent, Scott Umlauf, Ge Liu, Jim Huleatt, Lynda Tussey, Slobodan Paessler

Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs

利用高产细菌表达技术生产的高效重组流感疫苗:应对全球大流行和季节性需求的解决方案

Song, Langzhou; Nakaar, Valerian; Kavita, Uma; Price, Albert; Huleatt, Jim; Tang, Jie; Jacobs, Andrea; Liu, Ge; Huang, Yan; Desai, Priyanka; Maksymiuk, Gail; Takahashi, Virginia; Umlauf, Scott; Reiserova, Lucia; Bell, Rodney; Li, Hong; Zhang, Yi; McDonald, William F; Powell, T J; Tussey, Lynda